What's new?
Introduction
Catheter ablation (CA) and electrophysiological studies (EPS) are widely performed and their numbers are constantly growing [1] . The CA/EPS are invasive procedures and venous access (VA)-related complications remain at substantial level [2] . Moreover, the widespread use of non-interrupted oral anticoagulants (OAC) during CA/EPS may increase bleeding adverse events associated with VA [3] . Recent studies showed that ultrasound-guided VA (USG-VA) can minimize the risk of VA-related complications [4] , however, data regarding large cohorts are missing. Additionally, in some patients, due to the small diameter of femoral vein (FV) or anatomical conditions leading to suboptimal vessel visualisation, USG-VA can still be a challenge. The Valsalva maneuver (VM) increases peripheral venous pressure [5] and diameter of FV, however, feasibility of supporting USG-VA with VM has not yet been investigated. Thus, the purpose of this study was to determine the safety and effectiveness of USG-VA in a large cohort and feasibility of additional support of USG-VA with VM and its impact on FV diameter.
Methods

Consecutive patients undergoing CA/EPS between November 2016 and April 2019, supported
with the USG-VA, were included to determine feasibility and complications associated with USG-VA. Patients in whom VA was obtained using anatomical palpation, recruited between November 2016 and September 2018, were used as controls (the anatomical-VA group).
Additionally, from the USG-VA cohort, a group of consecutive patients was enrolled between October 2017 and April 2018 to undergo USG-VA combined with VM. In these patients, the measurements of the right FV were obtained at baseline and during VM, both in horizontal and vertical axis.
The USG-VA was performed using the Esaote Biomedica 7050 AU3 ultrasound machine. In 5 patients, a portable ultrasound (Lumify, Phillips, Netherlands) was used to store still images for purposes of the study. The linear ultrasound probe (LA13A, Esaote Biomedica, Genoa, Italy) was placed inside a sterile sleeve (Dina-Hitex, Bielsko-Biala, Poland) with a small amount (approx. 1cm 3 ) of ultrasound gel (Zelpol USG, Centrum Medicum, Lodz, Poland). Next, the probe was placed at the groin, 1 cm below the inguinal ligament in a patient being in supine position. The FV was identified using ultrasound compression test as previously described [7] . Baseline vertical and horizontal measurements were obtained using ultrasound machine callipers. Efforts were made to minimize venous compression by ultrasound probe during measurements. Next, the VM was performed: the patient was asked to take a deep breath, hold air and to push on abdomen. The ultrasound screen was frozen and the FV measurements were repeated.
After performing the measurements, the VM was repeated and, using Seldinger technique, an USG-VA was obtained above sapheno-femoral junction. If more than one VA was necessary, the VM was repeated each time a new puncture was performed. An estimated access area (EAA), using horizontal (x) and vertical (y) FV measurements of each vein was calculated from the modified side surface area of a cylinder of elliptical base:
where "a" and "b" correspond with half axis of the ellipse (½ x and ½ y respectively) ( Figure   1 ).
Minor complications were defined as incidental arterial puncture, failure to achieve femoral vein cannulation and groin hematoma not requiring any intervention. Major complications included hematoma requiring blood transfusion or prolonged hospitalization, arterio-venous fistula and femoral artery pseudoaneurysm. These minor and major complications were used as composite safety endpoint.
Statistical analysis
Results are presented as mean (SD) or numbers and percentages. A two-tailed paired Student T-test was used to compare horizontal, vertical and EAA measurements at baseline and during VM. A Chi square test was used to compare qualitative variables. A P value < 0.05 was significant.
Results
A total number of 1564 FV accesses using ultrasound in 876 patients versus 172 FV accesses in 105 patients in the anatomical-VA group (1.8/patient vs 1.6/patient; P=0.51) were performed. Demographic and clinical characteristics of the studied groups are presented in Table 1 . The same operators performed procedures in the USG-VA and control groups. There were no major complications associated with VA. Minor adverse events related to USG-VA were less common in the USG-VA group than in controls (1.5% vs 6.7% P=0.001), resulting in a 4-fold decrease in the VA-related minor complication rate when USG was used ( Table 1) .
None of these events required interventional management.
In the subgroup of patients in whom USG-VA was supported with VM, FV cannulation was successful in all patients. There was no significant difference in demographic and clinical variables between patients with or without VM-supported USG-VA ( 2 ). An example of an increase in the FV diameter during VM is depicted in [0.2]cm 2 during VM (P < 0.001). There were no significant differences in the rate of minor adverse events between VM-supported and standard USG-VA (Table 2 ). Of note, 2 of 3 inadvertent femoral artery punctures occurred in two very first patients from VM-arm, thus this complication was mainly associated with a learning curve of VM-supported VA.
Discussion
The main finding of this study is that USG-VA is feasible and safer than standard anatomical approach. In addition, the VM significantly increases the FV diameter and further facilitates achieving venous access.
It is worth mentioning that in our study which included a large cohort of patients undergoing USG-VA, no major vascular access-related complications were observed.
Moreover, incidence of minor complications was very low when VA was supported with ultrasound and these minor events did not require any other specific treatment than prolonged manual compression. This suggest a very good safety profile when USG-VA is attempted. This is important due to the fact that number of CA is constantly increasing [8] .
Vascular-related complications are usually not lethal. However, when these occur, such complications are associated with bleeding, the need for transfusions, surgical interventions, prolonged hospital stay, increased morbidity, and may increase mortality [9] .
Thus, methods are sought to prevent such outcomes. In one meta-analysis of four trials the usage of USG-VA was associated with a 60% decrease in complication rates when compared to the anatomical puncture [10] . In our study we achieved a 4-fold decrease in minor events.
This may suggest that the benefits of USG-VA approach can be even higher than reported so far.
The USG-VA approach can be particularly desirable in patients undergoing CA for atrial fibrillation (AF). In one randomized trial which included patients undergoing AF ablation, the usage of USG-VA was associated with improved intra-procedural outcomes, although the difference in the composite primary endpoint (vascular complications requiring surgical treatment, retroperitoneal hematoma requiring blood transfusion or hemoglobin drop of 3 >g/dl, strong pain at the groin, prolonged hospital stay or requiring hospital re-admission) between the USG-VA and control group did not meet statistical significance [4] . In order to prevent possibly devastating embolic events associated with AF ablation, uninterrupted anticoagulation has been recommended [10, 11] . This, however, may lead to increased risk of bleeding [9] . Any possible peri-procedural vascular access-related events may require withholding of anticoagulation and this may increase the risk of stroke during the vulnerable post-CA period [12] . Thus, further improvement of USG-VA in AF subgroups, such as VM or figure-of-8 sutures, would be welcomed [13] .
Not surprisingly, VM resulted in a significant increase in the FV diameter and EAA.
Although there were no significant differences between VM and non-VM-guided USG-VA, a trend towards lower incidence of local complications was noted. The lack significant difference may be due to the low overall number of local complications and perhaps larger studies might have showed bigger differences. Non-significantly higher incidence of incidental femoral artery puncture when using USG, can be explained by early period of learning curve of this novel method of vascular access.
It can be speculated that the VM can be especially beneficial in those patients who have small FV diameters such as patients with low weight and females or patients with anatomical abnormalities. The VM-supported venous access can be suitable not only for those physicians who perform USG-VA but also for those who use anatomical landmarks for puncture or when ultrasound is not available.
Limitations
This study has several limitations. First of all this was not a randomized controlled trial, however, the groups were well balanced regarding demographic and clinical variables.
Secondly, despite large study sample, the cohort was heterogenous, and, for example, only 7% of patients underwent AF ablation. Thirdly, this study does not specify which CA subgroups may particularly benefit from VA supported access (i.e. patients undergoing cryoablation for AF requiring large 12F sheaths). Fourthly, patients under general anaesthesia are not eligible for VM-supported access.
Conclusions
The USG-VA for EPS and/or CA is feasible. Complication rates using USG-VA are low and are usually benign. VM is a simple way to significantly increase EAA of femoral veins and can additionally support USG-VA in some difficult cases. 
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